Key result
Vanoxerine blocked hERG, hCav1.2, and hNav1.5 channels at clinically relevant concentrations without producing proarrhythmia markers, explaining its lack of torsadogenicity.
Vanoxerine's potent hERG blockade is offset by its blockade of calcium and sodium channels (Multiple Ion Channel Effects), explaining its lack of torsadogenic liability and supporting its safety profile.
Answers are grounded in this paper and cite their sources.
Supports multi-channel blockade mitigating torsadogenicity in animal models; leaves open translation to clinical safety assessment.
Vanoxerine has been in clinical trials for Parkinsonism, depression and cocaine addiction but lacked efficacy. Although a potent blocker of hERG, it produced no serious adverse events. We attributed the unexpected result to offsetting Multiple Ion Channel Effects (MICE). Vanoxerine's effects were strongly frequency-dependent and we repositioned it for treatment of atrial fibrillation and flutter. Vanoxerine terminated AF/AFL in an animal model and a dose-ranging clinical trial. Reversion to normal rhythm was associated with QT prolongation yet absent proarrhythmia markers for Torsade de Pointes (TdP). To understand the QT/TdP discordance, we used quantitative profiling and compared vanoxerine with dofetilide, a selective hERG-blocking torsadogen used for intractable AF, verapamil, a non-torsadogenic MICE comparator and bepridil, a torsadogenic MICE comparator. At clinically relevant concentrations, verapamil blocked hCav1.2 and hERG, as did vanoxerine and bepridil both of which also blocked hNav1.5. In acute experiments and simulations, dofetilide produced early after depolarizations (EADs) and arrhythmias, whereas verapamil, vanoxerine and bepridil produced no proarrhythmia markers. Of the MICE drugs only bepridil inhibited hERG trafficking following overnight exposure. The results are consistent with the emphasis on MICE of the CiPA assay. Additionally we propose that trafficking inhibition of hERG be added to CiPA.
No takes yet. Share an insight, caveat, or question.
Obejero‐Paz et al. (2015) studied Cardiac arrhythmias (Atrial fibrillation/flutter). Vanoxerine vs. Dofetilide, verapamil, bepridil was evaluated on IC50 for hERG channel block (nM) (95% CI 7.2-11.8). Vanoxerine blocked hERG, hCav1.2, and hNav1.5 channels at clinically relevant concentrations without producing proarrhythmia markers, explaining its lack of torsadogenicity.
Synapse has enriched 10 related papers. Consider them for comparative context: